- Report
- February 2024
- 120 Pages
Global
From €4303EUR$4,750USD£3,709GBP
- Report
- July 2023
- 284 Pages
Global
From €3261EUR$3,600USD£2,811GBP
- Report
- April 2025
Global
From €6794EUR$7,500USD£5,856GBP
- Report
- April 2025
- 297 Pages
Global
From €6794EUR$7,500USD£5,856GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €7700EUR$8,500USD£6,637GBP
- Report
- October 2024
Global
From €3171EUR$3,500USD£2,733GBP
The Alanine Aminotransferase (ALT) market within the In Vitro Diagnostics (IVD) industry is a segment of the larger IVD market. ALT is an enzyme found in the liver and is used to diagnose liver diseases. ALT tests are used to detect and monitor liver damage, as well as to monitor the effectiveness of treatments. ALT tests are also used to diagnose and monitor other conditions, such as diabetes, heart disease, and cancer.
ALT tests are typically performed in a laboratory setting, using a variety of methods, such as enzyme-linked immunosorbent assays (ELISA), spectrophotometry, and immunoassays. The ALT market is expected to grow due to the increasing prevalence of liver diseases, as well as the increasing demand for accurate and reliable diagnostic tests.
Some of the major companies in the ALT market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Bio-Rad Laboratories, and Ortho Clinical Diagnostics. Show Less Read more